Background And Objectives: Proximal advanced gastric cancer that invades the greater curvature is often treated by prophylactic splenectomy because of a risk for metastasis to the splenic hilar lymph node (station No.10). We evaluated whether laparoscopic spleen-preserving splenic hilar dissection (SPSHD) could be a better approach.
Methods: We reviewed records of patients with proximal gastric cancer who underwent total gastrectomy with No.10 dissection between 2012 and 2018 using our in-house database set. We divided patients by whether they had received SPSHD or splenectomy, first to compare surgical outcomes, and subsequently to analyze survival outcomes among patients with tumors invading the greater curvature.
Results: Of 145 patients enrolled in this study, 82 had SPSHDs and 63 had splenectomies. All SPSHDs were laparoscopic; 80% of splenectomies were laparotomic. Morbidity ≥ grade III was seen in 8.5% of the SPSHD group and 11.1% of the splenectomy group. The median number of retrieved No. 10 nodes was three in each group. In multivariable analysis, SPSHD was not an independent prognostic factor among patients whose tumors invaded the greater curvature (n = 73). Among propensity-matched cohorts (n = 25 each), 5-year relapse-free survival rates were 77.6% in the SPSHD group and 49.9% in the splenectomy group.
Conclusion: Laparoscopic SPSHD can potentially replace prophylactic splenectomy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ejso.2020.11.133 | DOI Listing |
Front Immunol
November 2024
College of Basic Medical Sciences, Shanxi University of Chinese Medicine, Jinzhong, China.
Background: Autoimmune hepatitis (AIH) is a chronic liver inflammatory disease mediated by autoimmune reactions, the pathogenesis of AIH is probably related to the imbalance of intestinal flora. Yinchenhao decoction (YCHD) has been used to relieve AIH. However, the mechanisms underpinning YCHD's hepatoprotective effects with the gut microbito have not been fully revealed.
View Article and Find Full Text PDFAnn Surg Oncol
November 2024
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Lymphadenectomy (LND) is a crucial component of the curative surgical treatment of gastric cancer (GC). The LND serves to both accurately stage the disease and offer therapeutic benefits. At the time of "curative-intent" gastrectomy, D2 LND is the optimal treatment for patients with locally advanced GC due to its survival benefits and acceptable morbidity.
View Article and Find Full Text PDFEur J Surg Oncol
October 2024
Gastric Surgery Division, National Cancer Center Hospital, Tokyo, Japan.
Surg Endosc
November 2024
Department of Gastrointestinal Surgery, Guangdong Provincial Hospital of Traditional Chinese Medicine, NO.111 Dade Rd, Guangzhou, 510120, China.
Background: This study aims to investigate the feasibility and value of modular splenic hilar lymphadenectomy (MSHL) in LTG for advanced PGC located at the greater curvature.
Study Design: A retrospective-controlled research included 54 patients diagnosed with advanced PGC located at the greater curvature who underwent LTG combined with spleen-preserving hilar lymphadenectomy between January 2020 and December 2022 at the same treatment center. A total of 20 patients underwent classic splenic hilar lymphadenectomy (CSHL) using a medial approach (classic group), while 34 patients underwent MSHL (modular group).
Am J Case Rep
August 2024
Department of Pathology and Laboratory Medicine, Zucker School of Medicine, North Shore University Hospital/Long Island Jewish Medical Center, Northwell Health, Greenvale, NY, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!